Skip to content Carb-X
Carb-X
Boston University
Mobile Menu Toggle navigation
  • Sign Up
  • Contact
  • Twitter
  • LinkedIn
Carb-X
Boston University
Boston University
  • About CARB-X
    • Overview
    • Global Threat
    • Our Strategy
    • Stewardship and Access
    • Management & Staff
    • Joint Oversight Board
    • Advisory Board
    • Careers
    • Annual Reports
    • Boston University
  • Portfolio
    • Portfolio Product Developers
    • Portfolio-Pipeline
    • CARB-X Graduates
    • Spotlight on Science
    • Portfolio Acceleration Tools
  • Partners
    • Funding Partners
    • Global Accelerator Network
  • Apply
    • Funding Themes
    • Omnibus Solicitation
    • Application Process
    • Entering Portfolio
    • Apply Here
    • Applicant Questions
  • Resources
    • CARB-X Connect
    • Presentations
    • Videos
    • Publications
    • Education
    • PD Resources
    • Media Resources
    • AMR Test Directory
  • News
    • CARB-X News
    • Recommended News
    • In the News
    • Antibiotic Resistance
  • Events
  • About CARB-X
    • Overview
    • Global Threat
    • Our Strategy
    • Stewardship and Access
    • Management & Staff
    • Joint Oversight Board
    • Advisory Board
    • Careers
    • Annual Reports
    • Boston University
  • Portfolio
    • Portfolio Product Developers
    • Portfolio-Pipeline
    • CARB-X Graduates
    • Spotlight on Science
    • Portfolio Acceleration Tools
  • Partners
    • Funding Partners
    • Global Accelerator Network
  • Apply
    • Funding Themes
    • Omnibus Solicitation
    • Application Process
    • Entering Portfolio
    • Applicant Questions
  • Resources
    • Presentations
    • Videos
    • Publications
    • Education
    • PD Resources
    • Media Resources
    • AMR Test Directory
  • News
    • CARB-X News
    • Recommended News
    • In the News
    • Antibiotic Resistance
  • Events
  • Contact
  • Legal

Portfolio Company

  • Portfolio
  • >
  • Gallery
Baebies Inc.

Baebies Inc., Durham, NC, USA
www.baebies.com

FINDER Bacteremia
RAPID NEAR-PATIENT ID/AST 

Diagnostic for Neonatal Sepsis

Baebies is developing a novel small footprint diagnostic instrument for rapid diagnosis of neonatal sepsis. The system provides a two-fold diagnosis. First a rapid test of 15 minutes to determine if the infection is due to bacteria. This is followed by a post blood culture rapid 15-minute molecular test for pathogen identification and antibiotic sensitivity. The speed and sensitivity of these tests is underpinned by Baebies’ patented digital microfluidic technology. With a focus on small volumes and rapid testing, Baebies aims to meet an important medical need for neonates.

Current Development Stage: Feasibility

CARB-X Investment: Initial investment of up to $3.9m with potential option payments up to $7.7m.

Initial CARB-X Investment Date: February 1, 2021

Carb-X

Led by Boston University

Copyright 2023

  • Contact
  • Careers
  • Site Credits
  • Legal
  • Twitter
  • LinkedIn

Copyright 2023